SCHEMBL9062977

SCHEMBL9062977

CC=C(c1ccccc1)C(c1ccccc1)c1ccc(OC(C)N(C)C)cc1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 7/20 0.40
LTB4R2 Q9NPC1 7/20 0.40
ALOX5 P09917 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HSD17B10 Q99714 1/20 0.36
KDM4E B2RXH2 1/20 0.35
KMT2A Q03164 2/20 0.34
CYP2C9 P11712 2/20 0.34
MEN1 O00255 1/20 0.34
MAPT P10636 1/20 0.34
LMNA P02545 2/20 0.34
HTT P42858 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8768148 0.78 TDP1 (0.50) ALDH1A1HSD17B10KDM4EKMT2ACYP2C9
SCHEMBL7929087 0.76 CYP2D6 (0.55) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL2710225 0.76 CYP2D6 (0.55) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL8732737 0.76 CYP2D6 (0.55) ALDH1A1KDM4EKMT2AMEN1MAPT
SCHEMBL11267446 0.74 TDP1 (0.42) ALDH1A1HSD17B10KMT2ACYP2C9MEN1
SCHEMBL8611247 0.73 CYP19A1 (0.51) ALDH1A1CYP1A2
SCHEMBL7032426 0.73 CYP19A1 (0.51) ALDH1A1CYP1A2
SCHEMBL4620169 0.73 GAA (0.51) ALDH1A1KMT2AMAPT
SCHEMBL7598667 0.73 ELANE (0.57) ALDH1A1KMT2ALMNA
SCHEMBL7015768 0.73 MAOA (0.46) ALDH1A1KDM4EKMT2ACYP2C9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996035417-A1 COMBINATIONS OF ANTI-OESTROGEN COMPOUNDS AND PKC MODULATORS AND THEIR USE IN CANCER THERAPY CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1996-11-14 WO disclosed